Impact of Human Immunological Responses and Viral Genetic Diversity on Outbreak of Human Monkeypox Virus. A Comprehensive Literature Review Study: Impact of Immunity and Genetic Diversity on Monkeypox

Irsa  Shabbir; Faiza Habib; Muhammad Umar Habib; Abdul Qader; Aamna Habib; Sadia Rafique

doi:10.54393/pjhs.v5i09.1510

Authors

Irsa Shabbir Department of Pharmacy, Lyallpur Institute of Advanced Studies Faisalabad, Faisalabad, Pakistan
Faiza Habib Department of Physiology, Combined Military Hospital (CMH) Medical College, Lahore, Pakistan
Muhammad Umar Habib Department of Urology, Nusrat Fateh Ali Khan Hospital, Faisalabad, Pakistan
Abdul Qader Department of Pharmaceutical Chemistry, Government College University Faisalabad, Faisalabad, Pakistan
Aamna Habib Medina College of Pharmacy, The University of Faisalabad, Faisalabad, Pakistan
Sadia Rafique Department of Pharmacy, The University of Faisalabad, Faisalabad, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i09.1510

Keywords:

Monkeypox Virus, Host Immunity, Genetic Diversity, Immunological Response

Abstract

Monkeypox was caused by Monkeypox Virus (MPXV) and can infect both humans and animals. An understanding of the interplay between host immunity and genetic diversity was necessary to understand the etiology and epidemiology of monkeypox disease. Objective: To clarify how genetic differences and host immune responses interact when a moneypox infection occurs. Furthermore, we also aim to provide insights into individual variability in illness outcomes and possible treatment targets by investigating how distinct genetic profiles affect immune system activation and efficacy. Methods: Recent research on monkeypox, concentrating on the immune response mechanisms of the host and genetic variables linked to virus vulnerability have thoroughly analyzed. For this purpose, the data were searched from various research engines such as google scholar, pubmed, medline etc., by using different key words i.e., monkeypox and host immunity, monkeypox and antibodies interactions, monkeypox outbreak, mnkeypox strains. Conclusions: The way a monkeypox infection progresses and turns out was greatly influenced by the interplay between host genetic differences and immunological responses. Public health initiatives and the creation of tailored treatment plans can both benefit from the identification of genetic markers linked to immunological response profiles and vulnerability.

References

McCollum AM and Damon IK. Human monkeypox. Clinical Infectious Diseases. 2014 Jan; 58(2): 260-7. doi: 10.1093/cid/cit703.

Cho CT and Wenner HA. Monkeypox virus. Bacteriological Reviews. 1973 Mar; 37(1): 1-8. doi: 10.1128/MMBR.37.1.1-18.1973.

Ježek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. Journal of Infectious Diseases. 1987 Aug; 156(2): 293-8. doi: 10.1093/infdis/156.2.293.

Cohen J. Monkeypox outbreak questions intensify as cases soar. Science. 2022 May; 376(6596): 902-3. doi: 10.1126/science.add1583.

Reynolds MG and Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends in Microbiology. 2012 Feb; 20(2): 80-7. doi: 10.1016/j.tim.2011.12.001.

Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. International Journal of Epidemiology. 1988 Sep; 17(3): 643-50. doi: 10.1093/ije/17.3.643.

Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB et al. Monkeypox virus infection in humans across 16 countries-April-June 2022. New England Journal of Medicine. 2022 Aug; 387(8): 679-91. doi: 10.1056/NEJMoa2207323.

Otu A, Ebenso B, Walley J, Barceló JM, Ochu CL. Global human monkeypox outbreak: atypical presentation demanding urgent public health action. The Lancet Microbe. 2022 Aug; 3(8): e554-5. doi: 10.1016/S2666-5247(22)00153-7.

World Health Organization. Rapport mondial sur l'équité en santé pour les personnes handicapées: résumé d'orientation. World Health Organization; 2022 Dec.

Ferdous J, Barek MA, Hossen MS, Bhowmik KK, Islam MS. A review on monkeypox virus outbreak: New challenge for world. Health science reports. 2023 Jan;6(1):e1007.

Estep RD, Messaoudi I, O'Connor MA, Li H, Sprague J, Barron A, Engelmann F, Yen B, Powers MF, Jones JM, Robinson BA. Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. Journal of virology. 2011 Sep 15;85(18):9527-42.

Seang S, Burrel S, Todesco E, Leducq V, Monsel G, Le Pluart D et al. Evidence of human-to-dog transmission of monkeypox virus. The Lancet. 2022 Aug; 400(10353): 658-9. doi: 10.1016/S0140-6736(22)01487-8.

Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clinical Infectious Diseases. 2005 Dec; 41(12): 1742-51. doi: 10.1086/498115.

Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nature Medicine. 2022 Aug; 28(8): 1569-72. doi: 10.1038/s41591-022-01907-y.

Desingu PA and Nagarajan K. Genomic regions insertion and deletion in monkeypox virus causing multi-country outbreak-2022. bioRxiv. 2022 Jun: 2022-06. doi: 10.1101/2022.06.28.497936.

Elde NC, Child SJ, Eickbush MT, Kitzman JO, Rogers KS, Shendure J et al. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell. 2012 Aug; 150(4): 831-41. doi: 10.1016/j.cell.2012.05.049.

Oliveira GP, Rodrigues RA, Lima MT, Drumond BP, Abrahão JS. Poxvirus host range genes and virus-host spectrum: a critical review. Viruses. 2017 Nov; 9(11): 331. doi: 10.3390/v9110331.

Werden SJ, Rahman MM, McFadden G. Poxvirus host range genes. Advances in Virus Research. 2008 Jan; 71: 135-71. doi: 10.1016/S0065-3527(08)00003-1.

Denzler KL, Babas T, Rippeon A, Huynh T, Fukushima N, Rhodes L, Silvera PM, Jacobs BL. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques. Vaccine. 2011 Dec 6;29(52):9684-90.

Brandt TA, Jacobs BL. Both carboxy-and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. Journal of virology. 2001 Jan 15;75(2):850-6.

Chen X, Yuan W, Yang X, Shi Y, Zeng X, Huang J, Wang Y, Li S. Ultrasensitive and specific identification of Monkeypox Virus Congo Basin and west African strains using a CRISPR/Cas12b-Based platform. Microbiology Spectrum. 2023 Apr 13;11(2):e04035-22.

Zhou J, Xiao F, Huang X, Fu J, Jia N, Sun C, Chen M, Xu Z, Huang H, Wang Y. Rapid detection of monkeypox virus and differentiation of West African and Congo Basin strains using endonuclease restriction-mediated real-time PCR-based testing. Analytical Methods. 2024;16(17):2693-701.

Craig AW, Cosentino GP, Donzé O, Sonenberg N. The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. Journal of Biological Chemistry. 1996 Oct; 271(40): 24526-33. doi: 10.1074/jbc.271.40.24526.

Bratke KA, McLysaght A, Rothenburg S. A survey of host range genes in poxvirus genomes. Infection, Genetics and Evolution. 2013 Mar 1;14:406-25.

Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Journal of Biological Chemistry. 2001 Sep; 276(36): 33293-6. doi: 10.1074/jbc.R100016200.

Shan KJ, Wu C, Tang X, Lu R, Hu Y, Tan W, Lu J. Molecular evolution of protein sequences and codon usage in monkeypox viruses. Genomics, Proteomics & Bioinformatics. 2024 May 9;22(1).

Rodger G and Smith GL. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface. Journal of General Virology. 2002 Feb; 83(2): 323-32. doi: 10.1099/0022-1317-83-2-323.

Gupta T, Chahota R. Unique ankyrin repeat proteins in the genome of poxviruses-Boon or Wane, a critical review. Gene. 2024 Jul 9:148759.

Rabaan AA, Alasiri NA, Aljeldah M, Alshukairiis AN, AlMusa Z, Alfouzan WA, Abuzaid AA, Alamri AA, Al-Afghani HM, Al-Baghli N, Alqahtani N. An updated review on monkeypox viral disease: emphasis on genomic diversity. Biomedicines. 2023 Jun 26;11(7):1832.

Jitendra N, Agarwal P, Shukla N et al. Comparative genome analysis reveals insights into the driving forces behind Monkeypox virus evolution and sheds light on the active role of trinucleotide motif ATC. ESS Open Arch. 2023 Aug. doi: 10.22541/au.169259777.74293035/v1.

Fang Z, Monteiro VS, Renauer PA, Shang X, Suzuki K, Ling X, Bai M, Xiang Y, Levchenko A, Booth CJ, Lucas C. Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens. Cell research. 2023 May;33(5):407-10.

Zandi M, Shafaati M, Hosseini F. Mechanisms of immune evasion of monkeypox virus. Frontiers in microbiology. 2023 Feb 1;14:1106247.

Moss B. Smallpox vaccines: targets of protective immunity. Immunological reviews. 2011 Jan; 239(1): 8-26. doi: 10.1111/j.1600-065X.2010.00975.x.

Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N et al. Cross-neutralizing and protective human antibody specificities to poxvirus infections. Cell. 2016 Oct; 167(3): 684-94. doi: 10.1016/j.cell.2016.09.049.

Malik S, Ahmed A, Ahsan O, Muhammad K, Waheed Y. Monkeypox Virus: a comprehensive overview of viral pathology, immune response, and antiviral strategies. Vaccines. 2023 Aug 9;11(8):1345.

Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S et al. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proceedings of the National Academy of Sciences. 2008 Aug; 105(31): 10889-94. doi: 10.1073/pnas.0804985105.

Grossegesse M, Stern D, Hofmann N, Surtees R, Kohl C, Michel J, Nitsche A. Serological methods for the detection of antibodies against monkeypox virus applicable for laboratories with different biosafety levels. Journal of Medical Virology. 2023 Dec;95(12):e29261.

Xia A, Wang X, He J, Wu W, Jiang W, Xue S, Zhang Q, Gao Y, Han Y, Li Y, Peng X. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history. BMC biology. 2023 Oct 2;21(1):205.

Altindis M, Puca E, Shapo L. Diagnosis of monkeypox virus–An overview. Travel medicine and infectious disease. 2022 Nov 1;50:102459.

Stefano JS, e Silva LR, Kalinke C, de Oliveira PR, Crapnell RD, Brazaca LC, Bonacin JA, Campuzano S, Banks CE, Janegitz BC. Human monkeypox virus: Detection methods and perspectives for diagnostics. TrAC Trends in Analytical Chemistry. 2023 Oct 1;167:117226.

Gao F, He C, Liu M, Yuan P, Tian S, Zheng M, Zhang L, Zhou X, Xu F, Luo J, Li X. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice. Virology Journal. 2023 Jun 19;20(1):126.

Otter AD, Jones S, Hicks B, Bailey D, Callaby H, Houlihan C, Rampling T, Gordon NC, Selman H, Satheshkumar PS, Townsend M. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals. Nature Communications. 2023 Sep 23;14(1):5948.

Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV et al. Evasion of the innate immune type I interferon system by monkeypox virus. Journal of Virology. 2015 Oct; 89(20): .10489-99. doi: 10.1128/JVI.00304-15.

Perdiguero B, Pérez P, Marcos-Villar L, Albericio G, Astorgano D, Álvarez E et al. Highly attenuated poxvirus-based vaccines against emerging viral diseases. Journal of Molecular Biology. 2023 Aug; 435(15): 168173. doi: 10.1016/j.jmb.2023.168173.

Shafaati M and Zandi M. Human monkeypox (hMPXV) re‐emergence: host immunity status and current vaccines landscape. Journal of Medical Virology. 2023 Jan; 95(1): e28251. doi: 10.1002/jmv.28251.

Johnston SC, Johnson JC, Stonier SW, Lin KL, Kisalu NK, Hensley LE, Rimoin AW. Cytokine modulation correlates with severity of monkeypox disease in humans. Journal of Clinical Virology. 2015 Feb 1;63:42-5.

Singh V, Dwivedi S, Agrawal R, Sadashiv, Fatima G, Abidi A. The Human Monkeypox Virus and Host Immunity: Emerging Diagnostic and Therapeutic Challenges. Infect Disord Drug Targets. 2024 Aug. doi:10.2174/0118715265309361240806064619.

Yi XM, Lei YL, Li M, Li Z, Li S. The monkeypox virus-host interplays. Cell Insight. 2024 Jul 14:100185.

Suraweera CD, Hinds MG, Kvansakul M. Poxviral strategies to overcome host cell apoptosis. Pathogens. 2020 Dec; 10(1): 6. doi: 10.3390/pathogens10010006.

Shisler JL and Jin XL. The vaccinia virus K1L gene product inhibits host NF-κB activation by preventing IκBα degradation. Journal of Virology. 2004 Apr; 78(7): 3553-60. doi: 10.1128/JVI.78.7.3553-3560.2004.

Zaucha GM, Jahrling PB, Geisbert TW, Swearengen JR, Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Laboratory Investigation. 2001 Dec; 81(12): 1581-600. doi: 10.1038/labinvest.3780373.

Parnian R, Heydarifard F, Mousavi FS, Heydarifard Z, Zandi M. Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape. Journal of Innate Immunity. 2024 May 27;16(1):413-24.

Okamoto M, Tsukamoto H, Kouwaki T, Seya T, Oshiumi H. Recognition of viral RNA by pattern recognition receptors in the induction of innate immunity and excessive inflammation during respiratory viral infections. Viral immunology. 2017 Jul 1;30(6):408-20.

Johnson RF, Dyall J, Ragland DR, Huzella L, Byrum R, Jett C et al. Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route. Journal of Virology. 2011 Mar; 85(5): 2112-25. doi: 10.1128/JVI.01931-10.

Byrd D, Shepherd N, Lan J, Hu N, Amet T, Yang K et al. Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination. Journal of Virology. 2014 Jun; 88(12): 6819-31. doi: 10.1128/JVI.03726-13.

Li H, Huang QZ, Zhang H, Liu ZX, Chen XH, Ye LL, Luo Y. The land-scape of immune response to monkeypox virus. EBioMedicine. 2023 Jan 1;87.

Angelo KM, Smith T, Camprubí-Ferrer D, Balerdi-Sarasola L, Menéndez MD, Servera-Negre G et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. The Lancet Infectious Diseases. 2023 Feb; 23(2): 196-206. doi: 10.1016/S1473-3099(22)00651-X.

Pettke A, Filén F, Widgren K, Jacks A, Glans H, Andreasson S et al. Ten-week follow-up of monkeypox case-patient, Sweden, 2022. Emerging Infectious Diseases. 2022 Oct; 28(10): 2074. doi: 10.3201/eid2810.221107.

O’Shea J. Interim guidance for prevention and treatment of monkeypox in persons with HIV infection—United States, August 2022. MMWR. Morbidity and Mortality Weekly Report. 2022;71.

Taha TY, Townsend MB, Pohl J, Karem KL, Damon IK, Mbala Kingebeni P, Muyembe Tamfum JJ, Martin JW, Pittman PR, Huggins JW, Satheshkumar PS. Design and optimization of a monkeypox virus specific serological assay. Pathogens. 2023 Mar 1;12(3):396.

Matusali G, Petruccioli E, Cimini E, Colavita F, Bettini A et al. Evaluation of cross-immunity to the mpox virus due to historic smallpox vaccination. Vaccines. 2023 Sep; 11(10): 1541. doi: 10.3390/vaccines11101541.

Asquith W, Hueston L, Dwyer D, Kok J, Ko D, Fennel M, Rockett R, Rai NJ, Li Y, Sriramoju S, Sutor A. Characterizing the acute antibody response of monkeypox and MVA‐BN vaccine following an Australian outbreak. Journal of Medical Virology. 2024 Jan;96(1):e29407.

Hou R, Jiang Q, Cheng M, Dai J, Yang H, Yuan J, Li X, Tang X, Yu H. Identification of neutralizing antibodies against monkeypox virus using high-throughput sequencing of A35+ H3L+ B cells from patients with convalescent monkeypox. Virus Research. 2024 Sep 1;347:199437.

Cohn H, Bloom N, Cai GY, Clark JJ, Tarke A, Bermúdez-González MC, Altman DR, Lugo LA, Lobo FP, Marquez S, Amoako A. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study. The Lancet Infectious Diseases. 2023 Nov 1;23(11):1302-12.

Vance RE, Jamieson AM, Raulet DH. Recognition of the class Ib molecule Qa-1b by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. The Journal of Experimental Medicine. 1999 Dec; 190(12): 1801. doi: 10.1084/jem.190.12.1801.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct; 22(10): 597-613. doi: 10.1038/s41577-022-00775-4.

Thakur M, Das P, Sobti RC, Kaur T. Human monkeypox: epidemiology, transmission, pathogenesis, immunology, diagnosis and therapeutics. Molecular and Cellular Biochemistry. 2023 Sep;478(9):2097-110.

Liu L, Xu Z, Fuhlbrigge RC, Pena-Cruz V, Lieberman J, Kupper TS. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. Journal of Virology. 2005 Jun; 79(12): 7363-70. doi: 10.1128/JVI.79.12.7363-7370.2005.

Kang Y, Yu Y, Xu S. Human monkeypox infection threat: A comprehensive overview. PLOS Neglected Tropical Diseases. 2023 Apr 20;17(4):e0011246.

Shabbir I, Qader A, Ahmad Z, Tariq H, Davis M, Rafique S et al. Monkeypox Virus a Rising Concern in Current age: A Mini Review on Epidemiology, Clinical Manifestations and Therapeutic interventions. The Journal of Medical Research. 2023 Jul; 9(3): 58-62. doi: 10.31254/jmr.2023.9306.

Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity. 2006 Mar; 24(3): 341-8. doi: 10.1016/j.immuni.2006.02.006.

van den Broek M, Bachmann MF, Köhler G, Barner M, Escher R, Zinkernagel R et al. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-γ and nitric oxide synthetase 2. The Journal of Immunology. 2000 Jan; 164(1): 371-8. doi: 10.4049/jimmunol.164.1.371.

Thakur A, Mikkelsen H, Jungersen G. Intracellular pathogens: host immunity and microbial persistence strategies. Journal of Immunology Research. 2019 Apr; 2019(1): 1356540. doi: 10.1155/2019/1356540.

Ali E, Sheikh A, Owais R, Shaikh A, Naeem U. Comprehensive overview of human monkeypox: epidemiology, clinical features, pathogenesis, diagnosis and prevention. Annals of Medicine and Surgery. 2023 Jun 1;85(6):2767-73.

Sun H, Miao Y, Yang X, Guo L, Li Q, Wang J, Long J, Zhang Z, Shi J, Li J, Cao Y. Rapid identification of A29L antibodies based on mRNA immunization and high-throughput single B cell sequencing to detect Monkeypox virus. Emerging Microbes & Infections. 2024 Dec 31;13(1):2332665.

Dee K, Manali M, Bissett LA, Bone J, Magill C, Davis C, Willett BJ, Murcia PR. Smallpox vaccination campaigns resulted in age-associated population cross-immunity against monkeypox virus. Journal of General Virology. 2024 Jun 11;105(6):001999.

Aiman S, Ali Y, Malik A, Alkholief M, Ahmad A, Akhtar S, Ali S, Khan A, Li C, Shams S. Immunoinformatic-guided novel mRNA vaccine designing to elicit immunogenic responses against the endemic Monkeypox virus. Journal of Biomolecular Structure and Dynamics. 2024 Aug 12;42(12):6292-306.

Jiao P, Ma J, Zhao Y, Jia X, Zhang H, Fan W, Jia X, Bai X, Zhao Y, Lu Y, Zhang H. The nuclear localization signal of monkeypox virus protein P2 orthologue is critical for inhibition of IRF3-mediated innate immunity. Emerging Microbes & Infections. 2024 Dec 31;13(1):2372344.

Keasey S, Pugh C, Tikhonov A, Chen G, Schweitzer B, Nalca A et al. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PLOS One. 2010 Dec; 5(12): e15547. doi: 10.1371/journal.pone.0015547.

Howard AR, Senkevich TG, Moss B. Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein. Journal of Virology. 2008 Dec; 82(24): 12384-91. doi: 10.1128/JVI.01524-08.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613. doi: 10.1038/s41577-022-00775-4.

Grifoni A, Zhang Y, Tarke A, Sidney J, Rubiro P, Reina-Campos M, Filaci G, Dan JM, Scheuermann RH, Sette A. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans. Cell host & microbe. 2022 Dec 14;30(12):1662-70.

Saxena SK, Ansari S, Maurya VK, Kumar S, Jain A, Paweska JT et al. Re‐emerging human monkeypox: a major public‐health debacle. Journal of Medical Virology. 2023 Jan; 95(1): e27902. doi: 10.1002/jmv.27902.

Saghazadeh A, Rezaei N. Poxviruses and the immune system: Implications for monkeypox virus. International Immunopharmacology. 2022 Dec 1;113:109364.

Yang S, Wang Y, Yu F, Cheng R, Zhang Y, Zhou D, Ren X, Deng Z, Zhao H. Structural and functional insights into the modulation of T cell costimulation by monkeypox virus protein M2. Nature Communications. 2023 Aug 25;14(1):5186.

Criscuolo E, Giuliani B, Ferrarese R, Ferrari D, Locatelli M et al. Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II. Journal of Medical Virology. 2023 Mar;95(3):e28643. doi: 10.1002/jmv.28643.

Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S et al. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clinical and Vaccine Immunology. 2007 Oct; 14(10): 1318-27. doi: 10.1128/CVI.00148-07.

Agarwal P, Shukla N, Bhatia A, Mahfooz S, Narayan J. Comparative genome analysis reveals driving forces behind Monkeypox virus evolution and sheds light on the role of ATC trinucleotide motif. Virus Evolution. 2024 Jan 1;10(1):veae043. doi: 10.1093/ve/veae043.

Qu J, Zhang X, Liu K, Li Y, Wang T, Fang Z, Chen C, Tan X, Lin Y, Xu Q, Yang Y. A comparative evaluation of three diagnostic assays for the detection of human monkeypox. Viruses. 2024 Aug 12;16(8):1286.

Smith YE, Bray M, Whitehouse CA, Miller D, Mucker E, Manischewitz J et al. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. The Journal of Infectious Diseases. 2005 Feb; 191(3): 372-81. doi: 10.1086/427265.

Sklenovská N and Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Frontiers in Public Health. 2018 Sep; 6: 383729. doi: 10.3389/fpubh.2018.00241.

Hammerschlag Y, MacLeod G, Papadakis G, Sanchez AA, Druce J, Taiaroa G et al. Monkeypox infection presenting as genital rash, Australia, May 2022. Eurosurveillance. 2022 Jun; 27(22): 2200411. doi: 10.2807/1560-7917.ES.2022.27.22.2200411.

Hickman HD, Reynoso GV, Ngudiankama BF, Rubin EJ, Magadán JG, Cush SS et al. Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. Cell Host & Microbe. 2013 Feb; 13(2): 155-68. doi: 10.1016/j.chom.2013.01.004.

Dai R, Huang X, Yang Y. γδT cells are required for CD8+ T cell response to vaccinia viral infection. Frontiers in Immunology. 2021 Oct; 12: 727046. doi: 10.3389/fimmu.2021.727046.

Kannan S, Ali P, Sheeza A. Monkeypox: epidemiology, mode of transmission, clinical features, genetic clades and molecular properties. European Review for Medical & Pharmacological Sciences. 2022 Aug 15;26(16).

Remakus S, Rubio D, Lev A, Ma X, Fang M, Xu RH et al. Memory CD8+ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection. Cell Host & Microbe. 2013 May; 13(5): 546-57. doi: 10.1016/j.chom.2013.04.004.

McClain DJ, Harrison S, Yeager CL, Cruz J, Ennis FA, Gibbs P et al. Immunologic responses to vaccinia vaccines administered by different parenteral routes. Journal of Infectious Diseases. 1997 Apr; 175(4): 756-63. doi: 10.1086/513968.

Forni D, Cagliani R, Molteni C, Clerici M, Sironi M. Monkeypox virus: the changing facets of a zoonotic pathogen. Infection, Genetics and Evolution. 2022 Nov 1;105:105372.

Munier CM, Van Bockel D, Bailey M, Ip S, Xu Y, Alcantara S et al. The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype. Vaccine. 2016 Oct; 34(44): 5251-61. doi: 10.1016/j.vaccine.2016.09.009.

Littaua RA, Takeda A, Cruz J, Ennis FA. Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. Journal of Virology. 1992 Apr; 66(4): 2274-80. doi: 10.1128/jvi.66.4.2274-2280.1992.

Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb. 1 in a small animal model. Proceedings of the National Academy of Sciences. 2023 Feb 21;120(8):e2220415120.

Mazumder L, Hasan MR, Fatema K, Begum S, Azad AK, Islam MA. Identification of B and T Cell Epitopes to Design an Epitope‐Based Peptide Vaccine against the Cell Surface Binding Protein of Monkeypox Virus: An Immunoinformatics Study. Journal of Immunology Research. 2023;2023(1):2274415.